BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20510086)

  • 1. [Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions].
    Wang JW; Zhao S; Liu Y; Li J; Xu LM
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):304-8. PubMed ID: 20510086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing extracranial tumors using diffusion-weighted whole-body MRI.
    Lenz C; Klarhöfer M; Scheffler K; Winter L; Sommer G
    Z Med Phys; 2011 May; 21(2):79-90. PubMed ID: 20888200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
    Li S; Sun F; Jin ZY; Xue HD; Li ML
    J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
    Takano A; Oriuchi N; Tsushima Y; Taketomi-Takahashi A; Nakajima T; Arisaka Y; Higuchi T; Amanuma M; Endo K
    Ann Nucl Med; 2008 Jun; 22(5):395-401. PubMed ID: 18600417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.
    Kwee TC; van Ufford HM; Beek FJ; Takahara T; Uiterwaal CS; Bierings MB; Ludwig I; Fijnheer R; Nievelstein RA
    Invest Radiol; 2009 Oct; 44(10):683-90. PubMed ID: 19724232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.
    Miller FH; Hammond N; Siddiqi AJ; Shroff S; Khatri G; Wang Y; Merrick LB; Nikolaidis P
    J Magn Reson Imaging; 2010 Jul; 32(1):138-47. PubMed ID: 20578020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study.
    Lin C; Itti E; Luciani A; Zegai B; Lin SJ; Kuhnowski F; Pigneur F; Gaillard I; Paone G; Meignan M; Haioun C; Rahmouni A
    Invest Radiol; 2011 May; 46(5):341-9. PubMed ID: 21263330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the efficacy of diffusion-weighted imaging and PET-CT in diagnosis of nasopharyngeal cancer].
    Li H; Xie CM; Liu XW
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):791-2. PubMed ID: 22335915
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study: diffusion weighted whole body imaging with background body signal suppression and hybrid Positron Emission Computed Tomography on detecting lesions in oncologic clinics.
    Wang N; Zhang M; Sun T; Chen H; Huang Z; Yan L; Wang L; Li F; Chen Z
    Eur J Radiol; 2012 Jul; 81(7):1662-6. PubMed ID: 21477959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
    Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
    Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers.
    Usuda K; Zhao XT; Sagawa M; Matoba M; Kuginuki Y; Taniguchi M; Ueda Y; Sakuma T
    Ann Thorac Surg; 2011 Jun; 91(6):1689-95. PubMed ID: 21619964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
    Wang H; Wang XY; Jiang XX; Ye ZX
    Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance imaging and its application to cancer.
    Charles-Edwards EM; deSouza NM
    Cancer Imaging; 2006 Sep; 6(1):135-43. PubMed ID: 17015238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
    Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G
    Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of whole body MRI and diffusion-weighted MRI in detecting intranodal lesions in patients with lymphoma].
    Li Z; Hu DY; Xia LM; Feng DY; Peng L; Wang CY; Chu Q
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):695-8. PubMed ID: 19173913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma.
    Muhi A; Ichikawa T; Motosugi U; Sano K; Matsuda M; Kitamura T; Nakazawa T; Araki T
    J Magn Reson Imaging; 2009 Nov; 30(5):1005-11. PubMed ID: 19856432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.